Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo
This study aimed to evaluate the maternal and fetal results in women undergoing antihypertensive therapy (low aspirin or labetalol) with mild to severe chronic hypertension relative to women without medicines. This randomized multi-center clinical trial was performed with random division into three groups of 393 pregnant women with mild to moderate chronic hypertension. From the beginning of the pregnancy to the end of the puerperium, the low dosage aspirin group (n = 129), the labetalol group (n = 127), and the drug-free or control group (n = 126) reported both mother and child results. Major variations in the presence of...
Source: Cellular and Molecular Biology - June 27, 2021 Category: Molecular Biology Authors: Xuewen Xiang Fang Wang Ni Zhao Zhao Zhou Source Type: research
